Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: Implications for gene therapy strategies

Prostate Cancer and Prostatic Diseases

Volumn 6, Issue 1, 2003, Pages 6-11

  Pandha, H S ^a   Stockwin, L H ^b,c   Eaton, J ^a   Clarke, I A ^a   Dalgleish, A G ^a   Todryk, S M ^a   Blair, G E ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Oxford GlycoSciences   (United Kingdom)

Author keywords

Adenoviruses; Integrins; MHC class I molecules; Prostate cancer; Receptors

Indexed keywords

ADENOVIRUS VECTOR; CANCER VACCINE; INTEGRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; COXSACKIE VIRUS B; FEASIBILITY STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; FLOW CYTOMETRY; GENE THERAPY; GENES, MHC CLASS I; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRINS; LUMINESCENT PROTEINS; MALE; PROSTATIC NEOPLASMS; RATS; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037252386     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500611     Document Type: Article

References (30)

1. Hodi FS, Dranoff G. Genetically modified tumor cell vaccines. Surg Oncol Clin N Am 1998; 7: 471-485.
2. Hellstrom I, Hellstrom KE. Tumor vaccines - a reality at last? J Immunother 1998; 21: 119-126.
3. Mastrangelo MJ et al. Cellular vaccine therapies for cancer. Cancer Treat Res 1998; 94: 35-50.
4. Pardoll DM. Cancer vaccines. Nat Med 1998; 4(5 Suppl): 525-531.
5. Smith AE. Viral vectors in gene therapy. A Rev Microbiol 1995; 49: 807-838.
6. Harrington KJ et al. Gene therapy for prostate cancer: current status and future prospects. J Urol 2001; 166: 1220-1233.
7. Hutchin ME, Pickles RJ, Yarbrough WG. Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum Gene Ther 2000; 11: 2365-2375.
8. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000; 81 (Pt 11): 2573-2604.
9. Philipson L, Lonberg-Holm K, Pettersson U. Virus-receptor interaction in an adenovirus system. J Virol 1968; 2: 1064-1075.
10. Stevenson SC et al. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J Virol 1995; 69: 2850-2857.
11. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
12. Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
13. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356.
14. Hong SS et al. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. Embo J 1997; 16: 2294-2306.
15. McDonald D et al. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells. Gene Ther 1999; 6: 1512-1519.
16. Freimuth P et al. Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J Virol 1999; 73: 1392-1398.
17. Bewley MC et al. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999; 286: 1579-1583.
18. Roelvink PW et al. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 1999; 286: 1568-1671.
19. Hidaka C et al. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 1999; 103: 579-587.
20. Kaner RJ et al. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. Am J Respir Cell Mol Biol 1999; 20: 361-370.
21. Leon RP et al. Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci USA 1998; 95: 13159-13164.
22. Stockwin L et al. Engineered expression of the Coxsackie and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J Immunol Methods 2001; in press.
23. Honda T et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000; 77: 19-28.
24. Yamamoto H et al. Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma. Int J Cancer 1997; 74: 251-254.
25. Brodsky FM, Bodmer WF, Parham P. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol 1979; 9: 536-545.
26. Kimball ES, Fisher MC. Levamisole effects on major histocompatibility complex and adhesion molecule expression and on myeloid cell adhesion to human colon tumor cell lines. J Natl Cancer Inst 1996; 88: 109-116.
27. Hemmi S et al. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 1998; 9: 2363-2373.
28. Li Y et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999; 59: 325-330.
29. Miller CR et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 1998; 58: 5738-5748.
30. Scupoli MT et al. Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. Tissue Antigens 1996; 48(4 Pt 1): 301-311.